SCHEMBL4570790

SCHEMBL4570790

c1ccc(-c2c3c(c(-c4ccccc4)c4ccccc24)-c2ccc(-c4cc5oc6ccccc6c5c5ccccc45)c4cccc-3c24)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 2/20 0.36
▸ CA2 P00918 2/20 0.36
▸ HPGD P15428 3/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ GABRP O00591 1/20 0.35
▸ GABRD O14764 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ CA12 O43570 1/20 0.35
▸ TNKS O95271 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ ABCB1 P08183 1/20 0.35
▸ PARP1 P09874 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35
▸ AR P10275 1/20 0.35
▸ CYP19A1 P11511 1/20 0.35
▸ GABRA1 P14867 1/20 0.35
▸ GABRB1 P18505 1/20 0.35
▸ GABRG2 P18507 1/20 0.35
▸ DPP4 P27487 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22916737 0.90 CA1 (0.39) CA1CA2HPGDCYP3A4SMN1; SMN2
SCHEMBL17944704 0.85 CA1 (0.40) CA1CA2HPGDCYP3A4SMN1; SMN2
SCHEMBL4570781 0.84 ALOX5 (0.40) CA1CA2HPGDCYP3A4SMN1; SMN2
SCHEMBL4081880 0.82 ALOX5 (0.41) CA1CA2HPGDCYP3A4SMN1; SMN2
SCHEMBL4570777 0.82 ALOX5 (0.41) CA1CA2HPGDCYP3A4SMN1; SMN2
SCHEMBL4570783 0.82 ALOX5 (0.50) CA1CA2CYP19A1CDC14BCDC14A
SCHEMBL4570782 0.82 ALOX5 (0.50) CA1CA2CYP19A1CDC14BCDC14A
SCHEMBL17944698 0.81 CA1 (0.39) CA1CA2HPGDCYP3A4SMN1; SMN2
SCHEMBL22706665 0.81 CA1 (0.39) CA1CA2HPGDCYP3A4SMN1; SMN2
SCHEMBL17944866 0.81 CA1 (0.42) CA1CA2HPGDCYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120112179-A1 FLUORANTHENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-05-10 — — US disclosed
US-20120112179-A1 FLUORANTHENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-05-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120112179-A1 FLUORANTHENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME AFF1, TCF12, AFF2 CA1 4348/4885CA2 3910/4885HPGD 4489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback